Cue Biopharma
39 hedge funds and large institutions have $37.4M invested in Cue Biopharma in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.16% more ownership
Funds ownership: 9.48% → 15.64% (+6.2%)
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.78M | |
| 2 | +$5.02M | |
| 3 | +$2.57M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.18M |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$410K | |
| 3 | -$232K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$13.4K |
| 5 |
Barclays
London,
United Kingdom
|
-$6.36K |